Search results for Xentuzumab
Xentuzumab Biosimilar – Anti-IGF1, IGF2 mAb – Research Grade, ProteoGenix, PX-TA1409
Description of Xentuzumab Biosimilar - Anti-IGF1, IGF2 mAb - Research Grade General information on Anti-IGF1/IGF2 [Homo sapiens] (Xentuzumab) Monoclonal Antibody Xentuzumab is investigated for the treatment of Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC).
Host
Reactivity
Applications
Conjugation
Xentuzumab, Abbexa, abx831367
Xentuzumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IGF1/IGF2, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.
Host
Human
Reactivity
Human
Applications
ELISA, WB
Conjugation
Unconjugated
Xentuzumab Biosimilar - Research Grade, ichor.bio, ICH5996
Host
CHO Cells
Reactivity
Human
Applications
Conjugation
Please provide the required information below so that we can quickly source your products.